Where do you start! What a disgraceful result.
A couple of things I’ve noticed besides the obvious. Debt has soared to $7.5m as at the end of the year.
Are we now looking at insolvency risk? The company has no cash!!! Only $362k at the end of last year. Hence why we aren’t receiving any dividend, they have no money…
Genuis still owes over $600k to Mayfield. They provide a vague statement, but it appears that we have paid for Genius centres upfront and before we have taken over Genius have kept all the income during that time with no adjustments being made. I still can’t understand why have not been paid this if this is correct. Why are we paying for centres upfront and not when settlement takes place?! Am I reading this wrong?
Frustratingly, the dividend we all expected is not coming and we now need approval from the bank to pay one!
I’m angry. This should have been a much-improved result, but it is awful and clearly shows how poor this management is. These people need to go before they completely wipe out all shareholder value.
- Forums
- ASX - By Stock
- MFD
- Ann: Annual Report to Shareholders
Ann: Annual Report to Shareholders, page-6
-
- There are more pages in this discussion • 12 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MFD (ASX) to my watchlist
(20min delay)
|
|||||
Last
53.3¢ |
Change
0.013(2.40%) |
Mkt cap ! $34.92M |
Open | High | Low | Value | Volume |
52.0¢ | 53.3¢ | 52.0¢ | $5.92K | 11.18K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 218 | 52.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
54.0¢ | 28000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 218 | 0.520 |
1 | 1000 | 0.515 |
1 | 19550 | 0.510 |
2 | 2675 | 0.500 |
1 | 1989 | 0.480 |
Price($) | Vol. | No. |
---|---|---|
0.540 | 28000 | 1 |
0.550 | 2744 | 1 |
0.560 | 14746 | 1 |
0.565 | 17366 | 2 |
0.570 | 20000 | 1 |
Last trade - 11.48am 12/11/2024 (20 minute delay) ? |
Featured News
MFD (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
SPONSORED BY The Market Online